Novartis Won't Face Punitives In Bone Drug Suit, Judge Says

Law360, New York (July 24, 2013, 9:40 PM EDT) -- A Florida federal judge on Monday said Novartis Pharmaceuticals Corp. will not face punitive damages in a lawsuit over jaw injuries allegedly caused by the bone drugs Aredia and Zometa.

Plaintiffs Ruth Dopson-Troutt and Frank Troutt argued that because U.S. District Judge Susan C. Bucklew already ruled that Pennsylvania law applied in the case, that state’s laws regarding punitive damages should also apply, but the judge instead agreed with Novartis that under the doctrine of “depecage,” New Jersey law applies and therefore punitive damages are precluded....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Dopson-Troutt et al v. Novartis Pharmaceuticals Corporation


Case Number

8:06-cv-01708

Court

Florida Middle

Nature of Suit

Personal Inj. Prod. Liability

Judge

Susan C Bucklew

Date Filed

September 15, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.